pharmaceuticals

Judge Colleen McMahon was expected to halt work on the controversial settlement that would give immunity from opioid lawsuits to the Sackler family. Instead she allowed work on the plan to go ahead.

How much the vaccine manufacturers stand to gain depends on how big the rollout proves to be.

At least three promising antiviral treatments for COVID-19 are being tested in clinical trials, with results expected as soon as late fall or winter.

Weeks after the FDA approved the Alzheimer's drug Aduhelm, doctors are struggling to figure out who should get the drug and how to use it safely.

Four big drug companies would pay out $26 billion to dozens of states over the next 17 years.

Massachusetts and New York are among the states agreeing to end the fight to halt a controversial Purdue Pharma bankruptcy plan. The deal shelters members of the Sackler family from opioid lawsuits.

Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it.

Johnson & Johnson says two small-sample lab studies that have not yet been peer-reviewed showed the one-dose shot is highly protective against the variant and that immunity may be long-lasting.

More than 100 bills have been introduced in 42 states this year to regulate these companies, which serve as conduits for drug manufacturers, health insurers and pharmacies.

Research involving crayfish spotlights the issue of medications entering the environment through improper disposal or excreting amounts in the bathroom.